These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25364867)

  • 1. Inhibiting the deubiquitinating enzymes (DUBs).
    Ndubaku C; Tsui V
    J Med Chem; 2015 Feb; 58(4):1581-95. PubMed ID: 25364867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deubiquitinases (DUBs) and DUB inhibitors: a patent review.
    Farshi P; Deshmukh RR; Nwankwo JO; Arkwright RT; Cvek B; Liu J; Dou QP
    Expert Opin Ther Pat; 2015; 25(10):1191-1208. PubMed ID: 26077642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward understanding ubiquitin-modifying enzymes: from pharmacological targeting to proteomics.
    Lill JR; Wertz IE
    Trends Pharmacol Sci; 2014 Apr; 35(4):187-207. PubMed ID: 24717260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Discovering Deubiquitinating Enzyme (DUB) Inhibitors.
    Schauer NJ; Magin RS; Liu X; Doherty LM; Buhrlage SJ
    J Med Chem; 2020 Mar; 63(6):2731-2750. PubMed ID: 31682427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deubiquitinating enzyme inhibitors and their potential in cancer therapy.
    Crosas B
    Curr Cancer Drug Targets; 2014; 14(6):506-16. PubMed ID: 25088039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of deubiquitinating enzyme activity via a suicidal HA-Ub-VS probe.
    Rivard C; Bazzaro M
    Methods Mol Biol; 2015; 1249():193-200. PubMed ID: 25348307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the Development Ubiquitin-Specific Peptidase (USP) Inhibitors.
    Chen S; Liu Y; Zhou H
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deubiquitinase inhibition as a cancer therapeutic strategy.
    D'Arcy P; Wang X; Linder S
    Pharmacol Ther; 2015 Mar; 147():32-54. PubMed ID: 25444757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecules as tools for functional assessment of deubiquitinating enzyme function.
    Magin RS; Liu X; Felix A; Bratt AS; Chan WC; Buhrlage SJ
    Cell Chem Biol; 2021 Jul; 28(7):1090-1100. PubMed ID: 34089649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of selective deubiquitinase inhibitors.
    Varca AC; Casalena D; Chan WC; Hu B; Magin RS; Roberts RM; Liu X; Zhu H; Seo HS; Dhe-Paganon S; Marto JA; Auld D; Buhrlage SJ
    Cell Chem Biol; 2021 Dec; 28(12):1758-1771.e13. PubMed ID: 34129829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging potential of therapeutic targeting of ubiquitin-specific proteases in the treatment of cancer.
    Pal A; Young MA; Donato NJ
    Cancer Res; 2014 Sep; 74(18):4955-66. PubMed ID: 25172841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deubiquitinases in cancer.
    Wei R; Liu X; Yu W; Yang T; Cai W; Liu J; Huang X; Xu GT; Zhao S; Yang J; Liu S
    Oncotarget; 2015 May; 6(15):12872-89. PubMed ID: 25972356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Advances in the Discovery of Deubiquitinating Enzyme Inhibitors.
    Kemp M
    Prog Med Chem; 2016; 55():149-92. PubMed ID: 26852935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecule inhibitors reveal allosteric regulation of USP14 via steric blockade.
    Wang Y; Jiang Y; Ding S; Li J; Song N; Ren Y; Hong D; Wu C; Li B; Wang F; He W; Wang J; Mei Z
    Cell Res; 2018 Dec; 28(12):1186-1194. PubMed ID: 30254335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deubiquitinases and the new therapeutic opportunities offered to cancer.
    Pfoh R; Lacdao IK; Saridakis V
    Endocr Relat Cancer; 2015 Feb; 22(1):T35-54. PubMed ID: 25605410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diarylcarbonates are a new class of deubiquitinating enzyme inhibitor.
    Long MJC; Lawson AP; Baggio R; Qian Y; Rozhansky L; Fasci D; El Oualid F; Weerapana E; Hedstrom L
    Bioorg Med Chem Lett; 2019 Jan; 29(2):204-211. PubMed ID: 30528168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decision for cell fate: deubiquitinating enzymes in cell cycle checkpoint.
    Lim KH; Song MH; Baek KH
    Cell Mol Life Sci; 2016 Apr; 73(7):1439-55. PubMed ID: 26762302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harnessing the oxidation susceptibility of deubiquitinases for inhibition with small molecules.
    Ohayon S; Refua M; Hendler A; Aharoni A; Brik A
    Angew Chem Int Ed Engl; 2015 Jan; 54(2):599-603. PubMed ID: 25327786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of VHR phosphatase inhibitors with micromolar activity based on structure-based virtual screening.
    Park H; Jung SK; Jeong DG; Ryu SE; Kim SJ
    ChemMedChem; 2008 Jun; 3(6):877-80. PubMed ID: 18236492
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms, biology and inhibitors of deubiquitinating enzymes.
    Love KR; Catic A; Schlieker C; Ploegh HL
    Nat Chem Biol; 2007 Nov; 3(11):697-705. PubMed ID: 17948018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.